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Abstract 
When interests and preferences of researchers or their sponsors cause bias in 
experimental design, data interpretation or dissemination of research results, we 
normally think of it as an epistemic shortcoming. But as a result of the debate on 
science and values, the idea that all “extra-scientific” influences on research could 
be singled out and separated from pure science is now widely believed to be an 
illusion. I argue that nonetheless, there are cases in which research is rightfully 
regarded as epistemologically deficient due to the influence of preferences on its 
outcomes. I present examples from biomedical research and offer an analysis in 
terms of social epistemology. 
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––––––––––––––––––––––––––––– 
Bias is becoming increasingly recognized as a serious problem in many areas of 
scientific research. Of particular concern are cases in which research results seem 
directly to reflect the preferences and interests of certain actors involved in the 
research process. Troubling examples of this have been identified, especially in 
privately funded research and in policy-related areas.  
Intuitively (and traditionally) it seems clear that the suggested kind of bias 
constitutes outright epistemic failure. But philosophers of science have begun to 
realize that the ideal of pure and value-free science is at best just that—an ideal—
and that all scientific practice involves all kinds of value-judgments. While some 
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philosophers have sought to distinguish acceptable from unacceptable influences 
of values on science, efforts to draw this distinction in a principled way have 
proven immensely difficult (see sec. 5). So why should not some values that inform 
scientific research be, e.g., shareholder values? 
My primary aim in this paper is to describe and define the suggested kind of 
bias in a way that allows us to characterize it as an epistemic shortcoming of the 
research in question. I will end up arguing that one need not deny the inevitable 
value-ladenness of science in order to mark certain cases of bias as being 
scientifically unacceptable. 
Note that my aim is not to analyze the concept of bias. There are many widely 
differing uses of “bias” both within science and within philosophy—enough to 
suggest that the word is polysemic (cf. Gluud 2006, Goldman 1999, sec. 8.3, Resnik 
2000). I am interested in a certain phenomenon, which I will introduce with the help 
of examples in the following section and try to characterize provisionally. 
1. Preference bias  
In the context of science and values, a phenomenon that I will call preference bias is 
of particular interest. It occurs when a research result unduly reflects the 
researchers’ preference for it over other possible results. (Note that this is a special 
kind of bias; the term ‘bias’ is also often applied to cases of systematic error that 
need have nothing to do with investigators’ preferences for one result or another. 
A classic example is the kind of bias in clinical trials introduced by incomplete 
randomization, which tends to re-confirm, if anything, the researchers’ 
preconceived beliefs rather than their preferences. Cf. Gluud 2006, pp. 494-495) One 
important caveat is that preference bias should be distinguished from outright 
falsification or fabrication of results. Preference bias works in a more subtle way, 
by increasing the likelihood of the preferred outcome rather than by bluntly 
fabricating it. 
Before I turn to the task of giving a more precise and satisfactory 
characterization of preference bias, I would like to present some examples of the 
phenomenon that have recently raised concern in the biomedical literature. They 
illustrate the variety of mechanisms by which the researchers’ preferences can 
come to exert a problematic kind of influence on the research result. Particular 
cases of preference bias are almost always controversial. For the concerns of this 
paper, it is inessential whether the controversies over either of the following 
examples can be considered resolved. What interests us here is the charge that 
preference bias has compromised the research in question, and the philosophical 
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problem of how best to characterize the kind of shortcoming that is implied by 
such a charge.  
Bisphenol A is used as a monomer in polycarbonate plastic and has been 
related to cancer and other health problems. Its toxicity is associated with its 
similarity to human estrogen. A controversial issue is the health risk of exposure to 
low doses. Biomedical scientists Frederick vom Saal and Claude Hughes noted that 
90% of government-funded experiments on low-dose exposure to bisphenol A 
reported significant effects, while not a single industry-funded experimental study 
did so (vom Saal & Hughes 2005). What is more, they found that some industry 
studies used a strain of rat (the CD-SD strain) that is particularly insensitive to any 
estrogen. Two industry studies initially included positive control groups that were 
exposed to the well-characterized estrogenic drug DES. The positive and negative 
controls failed to exhibit significant differences; this could have alerted the 
investigators to the unsuitability of their strain of experimental animal. Instead, in 
both cases the researchers chose to ignore this outcome and not to mention the 
positive control in their publications. Subsequent industry-funded studies simply 
omitted a positive control (vom Saal & Hughes 2005, pp. 928-929, vom Saal & 
Welshons 2005, p. 52). If these characterizations are adequate, the respective 
industry-funded studies on bisphenol A may be said to suffer from biased 
experimental design. The design of the studies made it unlikely to detect any effects. 
Biased experimental design may also afflict some randomized drug trials. At 
least, that is one plausible explanation of the frequently observed phenomenon 
that results of trials are significantly more favorable towards experimental 
interventions when they are funded by for-profit organizations (see e.g. Kjaergard 
& Als-Nielsen 2002; cf. Bekelman et al. 2003 and Lexchin et al. 2003 for systematic 
reviews). One factor contributing to this effect may be due to the choice of control 
intervention. Helle Johansen and Peter Gøtzsche (1999) have criticized industry-
funded studies of the antifungal agent fluconazole for unfairly comparing this 
intravenously administered drug with a control intervention of nystatin that was 
orally administered and thus relatively poorly absorbed. Benjamin Djulbegovic 
and colleagues (2000) investigated 136 published randomized trials on patients 
with multiple myeloma and found that most industry sponsored studies (which 
were on the whole much more likely to end up favoring the experimental 
treatment) compared the experimental intervention to a placebo or to no therapy, 
while most publicly sponsored studies by far used an active (standard) control 
therapy as comparator. The funding effect may thus be in part caused by a 
particular kind of biased experimental design, viz. use of a substandard 
comparison. 
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Preference bias can also be found after experiments, trials or studies have 
been performed in accordance with a certain design. Another toxic substance used 
for polymerization is vinyl chloride. Its toxicity is in many respects well 
established, including its carcinogenic agency with regard to cancer of the liver. 
However, its link with other kinds of cancer became subject to protracted dispute, 
despite accumulating evidence for its linkage with, among others, cancer of the 
brain (cf. Sass et al. 2005, Markowitz & Rosner 2002, ch. 7). In 1988, a review of 
epidemiological data from several European and North American studies on men 
occupationally exposed to vinyl chloride reported an increased occurrence of brain 
cancer, the standardized mortality ratio (SMR, i.e. the ratio of observed deaths to 
expected deaths times 100) being 148. In his interpretation of this result, Richard 
Doll, the author of the review, chose one small contributing study and subtracted 
the four cases of brain cancer death reported by it from the total in his survey, on 
the grounds that this study was itself the origin of the hypothesis that vinyl 
chloride might cause brain cancer and therefore this hypothesis should be tested 
by the remaining data, and also because it was “not a cohort study” (Doll 1988, p. 
70). Note that no similar operation is performed during the interpretation of the 
many other results of the survey. After this operation, there is still an excess of 
brain cancer (SMR = 131), but the total numbers are now too small to be statistically 
significant. Doll concluded: “No positive evidence of a hazard of […] any type of 
cancer other than angiosarcoma of the liver has been found […]”. Three years later, 
another study found excess deaths from cancer of the brain and the central 
nervous system “confirmed,” reporting a SMR of 180 (Wong et al. 1990). But soon 
after, two of its authors recanted and re-interpreted their findings as a possible 
product of “diagnostic sensitivity bias,” due to “more complete reporting and/or 
diagnoses of brain tumors in employees of large corporations than in the general 
population” (Wong and Whorton 1993). A decade later, a third study again 
reported excess brain cancer deaths among exposed workers (SMR 142, and SMR 
177 among subjects with the longest work history), but when they turned to an 
interpretation of their findings regarding mortality from brain cancer, the authors 
commented that “its relation with exposure to vinyl chloride remains unclear” 
(Mundt et al. 2000, p. 774). Jennifer Sass and colleagues (2005) have concluded that 
the evidence for the linkage of vinyl chloride with brain cancer has been 
consistently downplayed. They also point to the fact that all three studies were 
commissioned by the chemical industry. There is evidence that the remarkable 
recantation of Wong and Whorton was prompted by members of the Vinyl 
Chloride Panel of the Chemical Manufacturer’s Association (Markowitz & Rosner 
2002, pp. 229-230). If this characterization of the story is accurate, then the example 
provides ample illustration of how biased interpretation of outcomes is possible: 
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Outcomes can be declared irrelevant, they can be attributed to a speculative 
alternative cause, or they can be declared insufficient for the validation of a 
decisive conclusion. 
One additional kind of bias that needs to be addressed is biased communication 
and dissemination of results. Here, the best known phenomenon is publication bias, 
due to the fact that only a portion of all research results are published. Experiments 
or trials with significant outcomes are much more likely to be published than such 
with null or weak results, with the result that the overall picture in the scientific 
literature (as captured, for example, in literature reviews and meta-analyses) is in 
some cases significantly distorted (see Song et al. 2000 for review and 
comprehensive analysis). Editorial practices and journal referee decisions are 
thought to be partially responsible for publication bias (ibid., pp. 28-30). But also 
the reluctance of investigators or their sponsors to see unwelcome results 
published is known to contribute to the effect, in which case we are confronted 
with clear cases of preference bias (ibid., pp. 30-32). There is evidence to suggest 
that in biomedical research, subtle and not so subtle mechanisms frequently 
prevent or delay dissemination of results when they run counter to the business 
interests of sponsors (Blumenthal et al. 1997). Recently, evidence has solidified that 
selective publication does not only affect complete studies, but that also within 
studies (which typically result in a large set of outcomes), outcomes are often 
reported selectively, depending on the nature of each respective result. Cautiously, 
the authors of the respective investigation note that as a result, the published 
literature may “overestimate the benefits of an intervention” (Chan et al. 2004, p. 
2457). 
These cases give only a small sample of the many ways in which judgements 
and decisions of scientists can be affected, and they can only hint at the larger 
consequences for science (for a wealth of cases, see Krimsky 2003, Resnik 2007). 
Nevertheless, the examples given suffice to illustrate how preferences of 
investigators (and indirectly also preferences of research sponsors) can exert their 
influence on research outcomes at several major steps of the research process. In 
the following section, I will consider a preliminary and intuitive way of analyzing 
such influences as biases. Although the analysis will under closer scrutiny turn out 
to be problematic, it is helpful in identifying the common traits of the cases at issue 
and in approaching the underlying epistemological problems. 
2. Preference bias and inductive risk 
In every empirical investigation that is designed to test some hypothesis H, two 
kinds of risk can be identified: the risk that the investigation may lead to the 
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acceptance of H while H is in fact false, and, conversely, the risk of rejecting H 
when H is in fact true. Carl Hempel (1965, pp. 91-92) has coined the term 
“inductive risk” to cover these two types of risk. It was recognized early on in the 
development of statistics that in contexts relevant for practical applications, the 
consequences of the two types of error are typically borne by different parties. 
Inspired by the terminology of quality control, one of the most important early 
applications of statistics, it became common to label one type of risk (originally, the 
risk of falsely rejecting a good product) “producer’s risk” and the other 
“consumer’s risk” (see e.g. Pearson 1933).  
While a good experiment, study or trial is always designed to lower the total 
risk of leading to a false conclusion, this risk cannot be minimized beyond a certain 
limit without increasing the empirical input. However, the crucial insight in our 
context is that one type of inductive risk can usually be traded off against the other 
type without changing the size of the empirical basis, by means of alterations 
regarding experimental design, data analysis or even dissemination of results. E.g., 
by their choice of a particular strain of rat, researchers investigating the effects of 
low-dose exposure to bisphenol A reduced the risk of falsely postulating an effect 
where there is in fact none, while by the same move they increased the risk of 
negating effects that really exist.  
In all our examples for preference bias, it may plausibly be assumed that the 
involved actors’ preferences have induced them to trade off a decreased producer’s 
risk against an increased consumer’s risk. (For cases of publication bias, this 
presupposes that the relevant sense of acceptance of the hypothesis is understood 
as acceptance within the community that absorbs the published research 
literature.) Motivated by this common feature, let us consider the possibility to 
simply conceive of preference bias as the result of tampering with the balance of 
inductive risks. According to this idea, preference bias would be regarded as a 
researcher’s failure to be impartial between the two kinds of risk, and allowing her 
different attitudes with regard to the desirability of a positive or negative result to 
influence the set-up of the test or even the whole research project in such a way 
that one type of inductive risk is decreased at the expense of the other’s 
amplification. This analysis could cover manipulations intentionally introduced by 
the investigator in order to increase the chance of arriving at the desired results, as 
well as subconscious influences of her preferences on her methodological choices. 
3. Inductive risk and the evaluation of outcomes 
This tentative analysis of preference bias in terms of inductive risk seems to face a 
serious problem, though. The analysis under consideration starts from the implicit 
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assumption that there is a certain correct or impartial balance between the two 
kinds of inductive risk that exists independent of the researcher’s preferences, and 
that preference bias consists in the deviation from that balance. However, it has 
long been argued that in cases where the aim is to accept or reject a hypothesis on 
the basis of evidence, there is no non-arbitrary and convincing way to strike a 
correct balance of inductive risks independent of certain value-judgments. The 
point was first argued explicitly by statisticians such as Abraham Wald (1942, pp. 
40-41) and C. West Churchman (1948, ch. 15), but came to prominence through a 
brief paper by Richard Rudner (1953). It remains one of the most forceful 
arguments for the inevitability of value-judgments within scientific research. 
The argument is quite simple and straightforward. No empirical hypothesis 
is ever completely verified by the data. In order to accept a hypothesis, a scientist 
must decide which level of inductive confirmation she considers sufficient for 
acceptance. With regard to the analysis and interpretation of the data, in classical 
statistics this choice is most obviously present in the selection of a level of 
significance, but as we have seen, all kinds of decisions at all levels of the design 
and execution of an empirical investigation have an influence on how strong the 
evidence will have to be in order to actually lead to the hypothesis’ acceptance. The 
appropriateness of these decisions depends on the minimum level of probability 
that the investigator chooses to be sufficient for the acceptance of the hypothesis, 
and there is nothing in the science of statistics or in the logic of inductive reasoning 
to determine this choice. Instead, Churchman and Rudner argue, the researcher’s 
evaluation of the possible outcomes of the investigation will have to determine the 
choice. In particular, the evaluation of the two kinds of possible mistakes should 
make a difference to the minimum degree of confirmation at which the hypothesis 
becomes acceptable. “How sure we need to be before we accept a hypothesis will 
depend on how serious a mistake would be.” (Rudner 1953, p. 2) Therefore, “the 
value of any test procedure depends upon a certain function of both the chance of 
error and the loss.” (Churchman 1948, p. 256) That is to say, how good or bad a 
given empirical investigation suits its purpose is always relative to value-judgments 
regarding the potential loss that each kind of mistake would entail. Such 
judgments are therefore part and parcel of the researchers’ task of designing and 
selecting test procedures for hypotheses. (Of course, everything that this argument 
says about accepting hypotheses applies equally, mutatis mutandis, to rejecting 
them.) 
One immediate rejoinder to this argument was formulated by Richard Jeffrey 
(1956). He argued that the scientist’s task, properly understood, was not to reject or 
accept hypotheses, but rather to establish their degree of confirmation in light of 
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the available empirical evidence. It is only in decisions about whether or not to act 
on the basis of a given hypothesis that value-judgments about the possible 
consequences of errors come into play. When such decisions are made, the 
probabilities of the relevant hypotheses’ correctness as established by the scientists 
should by all means be taken into account, so Jeffrey’s rejoinder goes on, but this 
kind of decision-making will typically fall outside of the scientists’ own area of 
activity. 
One rather obvious shortcoming of Jeffrey’s response is its mismatch with 
reality, in particular with regard to the claim that scientists do not, or at any rate 
should not accept or reject hypotheses but only assign probabilities. Another, more 
rigorous point was pointed out by Heather Douglas (2000), whose work was vital 
for bringing the argument of Rudner and others back into the current debate about 
science and values. While Jeffrey’s rejoinder assumes that the need to evaluate the 
consequences would only arise at the end of the research process and only if the 
scientist tried to sum up her results in form of an accepted or rejected hypothesis, 
scientists in fact “also take inductive risks in stages of science before acceptance or 
rejection of theories, thus considering risks never brought to the light of public 
decision-making.” (Douglas 2000, p. 563) Douglas has shown that there are 
inductive risks involved in methodological choices, in evidence characterization 
and in the interpretation of results, and thus in all kinds of decisions that do 
patently fall within the scientist’s own area of work. When finally the hypothesis 
can be considered in light of the investigation’s results, the scientist will already 
have struck a particular balance between the two types of inductive risk on several 
occasions within the research process, and she will arguably have had to evaluate 
the consequences of errors in order to do so.  
So where does this all leave us with respect to our characterization of 
preference bias? It seems that as long as there is no principled way to distinguish 
the preferences among possible outcomes referred to in our definition of 
preference bias from the kinds of evaluations of possible outcomes that are always 
and inevitably present in scientific research according to Douglas, Rudner and 
others—and I can see no such way—, what we have called “preference bias” will 
simply be part of the scientific condition. In other words, it is prima facie not 
possible to distinguish cases of diverging judgments concerning the evaluation of 
consequences from cases of different preference biases as defined above. As it 
stands, this conclusion would make a big difference for the criticism of biased 
research. The controversial aspects of preference bias would seem to arise on the 
level of value-judgments. The researchers who chose to use a strain of rat that is 
particularly insensitive to estrogen in order to study the effects of low dose 
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exposure to bisphenol A did so as a result of their particular evaluation of the 
consequences of the possible outcomes of their study. Their evaluation presumably 
was that the possible overregulation that might have resulted from a false positive 
outcome of their studies would have been a particularly dreadful outcome. It 
seems to follow that we could only accuse them of having made a mistake or 
having applied an improper test procedure in the same sense in which we might 
also be prepared to say that someone makes a mistake or acts improperly by not 
holding the same values as we do.1 Bias-talk would thus be revealed as primarily 
involving the charge of a moral shortcoming. This result will surprise everyone 
who shares my intuition that whether or not the cases described in section 1 
display epistemological shortcomings is not relative to a set of personal value-
judgments. Of course, we all know that intuitions can be deceptive. Should we 
simply learn to live with the counter-intuitive moral analysis of bias? 
4. The ideal of purity 
There is one sense in which presumably everyone would agree that the 
shortcomings of cases of bias are relative to a value; they are at least relative to 
whichever value is ascribed to replacing ignorance with true belief. A possibility to 
save the intuition appealed to at the end of the last section might therefore be to 
describe the treatment of inductive risk as relative to this value and only this value. 
A response to the challenge of Churchman and Rudner along these lines was 
attempted by Issac Levi in a series of articles (1960, 1961, 1962). Slightly adapting 
one of his ideas (1962, pp. 55-56), one can develop the following Bayesian 
consideration. A researcher who is trying to design a test procedure for hypothesis 
H and who pursues the sole aim of replacing ignorance with true belief should 
ideally construct the procedure in such a way that it will select among the 
theoretical options as would a rational agent acting in accordance with the 
following utility matrix: 
 H is in fact true H is in fact false 
accept H 1 0 
reject H 0 1 
suspend judgment k k 
                                                          
1  Incidentally, note that this point of view comes close to a line of defense that is sometimes 
used by those accused of bias. For example, in an article written to defend industrial science 
against the charge of continued bias in the case of vinyl chloride, two industrial researchers 
make the appeal that “[o]f course, all scientists have biases”, invoking an open letter in which 
fifteen past presidents of the Society of Toxicology endorse that statement (Barrow and 
Conrad 2006, p. 154). 
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The fact that the utilities for both correct outcomes (accepting H when H is true 
and rejecting H when H is false) are equal and positive reflects the assumption that 
the respective investigation is geared to finding truth, and nothing else. For the 
same reason, zero utility is assigned to both kinds of error. It is assumed that 0 ≤ k 
≤ 1, because in an investigation such as this, ignorance must not be preferred over 
true belief and error must not be preferred over ignorance. Assuming that the goal 
is to maximize expected utilities, the values in this matrix determine just one 
unequivocal minimum confirmation level L = max{k, ½}, such that it is rational2 to  
accept H if Pr(H) > L, 
reject H if Pr(¬H) > L 
and otherwise to suspend judgment. 
How sure we need to be before we accept H is exactly the same as how sure we 
need to be before we reject H. 
The undetermined value of k might seem to be a weak point of the decision 
matrix. Levi (1962, pp. 56-57) interprets k as the “degree of caution” employed by a 
researcher. Note that k will realistically be larger than ½, as k ≤ ½ would mean to 
automatically recommend accepting a hypothesis as soon as it appears even 
slightly more likely than its negation. With a view to the often immense 
consequences of accepting a hypothesis for the continuing search for further truths, 
it is safe to assume that realistic values of k will be much larger than ½, even taking 
into account only the purely epistemic motives presupposed in our model 
situation. Levi grants that the choice of k implies that a scientist has to reckon with 
the seriousness of mistakes, but “only in the sense that the degree of caution that 
he adopts reflects how serious he considers making any mistakes to be in the 
relation to remaining in doubt” (ibid., p. 57). What is particularly relevant in our 
context is that whatever the choice of k (and however we conceive of the values 
that must undoubtedly play a role in determining it), a definite level (1 – L) of 
theoretically acceptable probability of error is thereby established and what is more, it 
is the same level for both types of error. A trade-off between consumer’s and 
producer’s risk would not be consistent with a test procedure with purely 
epistemic aims as characterized by Levi’s matrix. So far, it seems that the idea from 
the beginning of this section could work out: While different levels of acceptable 
inductive risk are compatible with an investigation solely designed to replace 
ignorance with true belief and avoid error, the balance of the two types of 
inductive risk is fixed in such a situation—the acceptable probability of a mistake 
                                                          
2  I shall here and henceforth exclude from discussion equivocal cases where expected utilities 
are exactly the same for two different options, as they are of no particular interest for the 
issues under discussion.  
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must be the same for both types of error. Any deviation from this balance must 
from this point of view be seen as reflecting the intrusion of other values in 
addition to the single epistemic value that this model admits and can in that sense 
be regarded as bias. I will call this concept of bias “L-bias”. 
5. Relaxed purity 
However, I submit that regarding L-bias as an analysis of real-world cases of 
preference bias would be much too simple. It presupposes a sense of purity of 
epistemic activity that is exaggerated and unrealistic. To begin with, it has long 
been recognized that science, even if conceived as essentially a truth-seeking 
enterprise, does not pursue each truth with the same eagerness. In the terminology 
introduced by Philip Kitcher, science aims to find significant truths, where 
significance is bestowed both by a proposition’s value for the systematic 
organization of our beliefs and by our interest in its application (Kitcher 1993, ch. 4, 
2001, ch. 6). It is now commonly acknowledged that even basic science must be 
understood to value a range of properties over and above mere truth: simplicity, 
unifying power and fruitfulness for the further development of science are 
examples of such widely accepted “epistemic values” (Kuhn 1977, McMullin 1983). 
There is no reason to assume that H and ¬H will normally score equally high with 
regard to all epistemic values, and hence the assumption that both “correct” 
outcomes must be assigned identical utilities seems amiss even by plausible 
standards for “pure science”.3 Additionally, a scientist’s decision to accept or reject 
H does not only have consequences for this one particular piece of knowledge but 
will typically bear on the subsequent development of a research program. Different 
decisions can open up or foreclose different opportunities to discover more truths. 
This even holds for the different possible mistakes. Hence, even with regard to 
replacing ignorance with true belief alone, differences in utility can arise even 
between the different kinds of mistakes and even between suspending judgment in 
case H is true and suspending judgment when H is false. Taking all this into 
account and indicating the utilities of the correct outcomes by c and c', the utilities 
of the errors by e and e', and the utilities of suspending judgment in different 
world states by k and k' (all assumed to be represented on an interval scale), do we 
have anything left to say about the following decision situation that would reflect a 
realistic ideal of a proper epistemic or scientific enterprise? 
                                                          
3  Maher (1993, 214-216) tries to defend the assumption by claiming that simplicity is only an 
instrumental goal of science, pursued solely in virtue of its presumed truth-conduciveness. I 
cannot imagine how this argument would carry over to other epistemic values like 
fruitfulness (and find it difficult to defend even for simplicity). 
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 H is in fact true H is in fact false 
accept H c e' 
reject H e c' 
suspend judgment k k' 
I think we can still plausibly maintain a relaxed ideal of purity by making the 
following assumptions: The values reflected in the design of a proper scientific 
investigation should be such that if H is in fact true, accepting it is preferable to 
suspending judgment, and that is in turn preferable to rejecting H, while if H is in 
fact false, rejecting H is preferable to suspending judgment, which in turn is 
preferable to accepting H. That is to say, we can plausibly impose the following 
order relations on our utilities: c > k > e and c' > k' > e'. Under the conditions 
implied by these, we can formulate a result that follows immediately from the 
comparison of the expected utilities: An ideal Bayesian agent would  
accept H if     Pr(H) > M1, 
reject H if     Pr(¬H) > M2 
and otherwise suspend judgment, 
where M1 = max








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−
−
−
−
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 and M2 = max
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
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
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−
−
−
−
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'e'c
ek
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1
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1
. 
To act in accordance with a set of utilities ordered as indicated above, scientists 
should ideally design their investigation in such a way that it emulates the 
behavior of this Bayesian agent. 
This result shows that a utility structure like the one given above does in fact 
provide an answer to Rudner’s question of how sure we need to be before we 
accept H in form of a minimum degree of confirmation level of M1.4 The exact 
levels of acceptable error probabilities for the two types of error are given by (1 – 
M1) and (1 – M2) respectively. We see that the balance of inductive risks 
commanded by our utility structure need not consist in an identity of levels for 
both types of error probabilities—even if the utilities are interpreted as expressing 
a purely epistemic interest in the investigation. We can read off how the balance 
                                                          
4  Note that analogously to the situation in Levi’s original matrix, the values for k and k' will in 
realistic cases be much closer to c and c' respectively than to e and e' respectively, as other 
constellations would mean a tendency to jump to conclusions on the slightest touch of 
evidence. Assuming this and a relative similarity between the intervals c – e and c' – e' means 
that in realistic situations, M1 = 
''
1
1
ek
kc
−
−+
 and M2 = 
ek
kc
−
−+ ''1
1
. 
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(or rather, imbalance) of risks may legitimately vary with the intervals between c, k 
and e on the one hand and c', k' and e' on the other. 
Does this result permit us to regard the values M1 and M2 as indicating the 
correct arrangement of inductive risks, and to consider any infringement thereof a 
case of preference bias? It seems that the only way to do this would be to claim that 
for every kind of empirical investigation, there exists an objectively determined set 
of purely epistemic utilities c, c', e, e', k and k' of its possible outcomes. A deviation 
of the effective thresholds for acceptance and rejection from M1 and M2 would then 
either be irrational or reflect the intrusion of other, “impure” utilities (subjective 
“preferences”) into the decision problem. 
However, the protracted debate on science and values has shown that it is 
deeply problematic to try and separate epistemic from non-epistemic, or cognitive 
from non-cognitive values. The common way to attempt such a separation is to 
claim that epistemic values are those that we believe to indicate the truth of the 
hypotheses or theories that possess them (McMullin 1983, p. 18). But the truth-
conduciveness of simplicity, fruitfulness and the like can hardly be called well 
established, so “our” belief in their usability as truth-indicator may very well differ 
from person to person (cf. Kourany 2003, p. 9). For example, feminist scientists and 
philosophers have criticized the widely shared “epistemic value” of external 
consistency (of new theories and hypotheses with older, established ones) as being 
an expression of the value-holders’ contentment with the status quo rather than an 
indicator of truth (cf. Longino 1996, pp. 51-52).  
Even if there was a definite set of epistemic values, it would still be 
implausible to assume that this set would objectively determine purely epistemic 
utilities for each and every possible outcome of any investigation. For such 
epistemic values as we can make out are individually imprecise and can conflict 
with each other, as has been observed many times (e.g., Kuhn 1977, p. 322, Laudan 
1984, pp. 37-38). (Note that cases of conflicting epistemic values can not be 
shrugged off as freak incidents. Some epistemic values, such as accuracy and 
breadth of scope, are in systematic tension with each other [cf. Longino 1996, p. 
44].) Their application to each individual case must therefore be effected by means 
of individual judgment.  
It may still seem that for all practical purposes, we can distinguish between 
acceptable and unacceptable value influences well enough. It is, after all, exactly 
the problem of conflicts of interests and bias that research ethicists like David 
Resnik have in mind when they articulate ethical and epistemological norms to 
guide and delineate acceptable scientific research (Resnik 2007, esp. ch. 2). 
Principles such as those proposed by Resnik will certainly find wide support and 
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can be used to rule out many important cases of objectionable conduct. However, 
they cannot solve all the problems with the examples introduced in this paper. For 
example, Doll explicitly justifies his move to exclude certain brain cancer cases 
from his calculations by referring to the methodological quality of the study that 
reported them and to the (alleged) fact that this study was itself the origin of the 
hypothesis to be tested. He thus implicitly appeals to principles of testability and 
empirical support (to use Resnik’s terms, cf. ibid., p. 48). So do Wong and Whorton 
in their remarkable recantation when they claim to be wary of diagnostic bias in 
their data. The various accepted principles of scientific research leave a lot of 
leeway for individual decisions to apply or not to apply a certain norm in a certain 
situation (they must leave this leeway, as they often pull in different directions). 
When this leeway is consistently used in favor of a certain kind of outcome, bias 
results. The difficulties I have been discussing in this section are thus not merely 
philosophical, and the efforts to distinguish between epistemic and non-epistemic 
values or between acceptable and unacceptable principles cannot solve all the 
problems—neither in theory, nor in practice. 
Together, the above considerations show that one cannot mark out one 
specific set of utilities for a given empirical investigation as the one that is 
determined by the objective, purely epistemic aims or values; one cannot even 
impose some restrictions on how such a utility structure is permitted to look (apart 
from the half order relations we have already been presupposing). Failing any such 
additional principled constraints on the character of the utilities c, c', e, e', k and k', 
there remains surprisingly little to say about legitimate test procedures from the 
perspective of individual rationality. What we can say is that there must be 
thresholds (genuinely between 0 and 1) such that when H’s degree of confirmation 
exceeds the threshold M1 (respectively falls below 1 – M2), the hypothesis should 
be accepted (or respectively rejected). But these thresholds could be very close to 1 
(or respectively 0). The cases discussed in section 1 do not seem to violate this 
restriction by making it absolutely impossible that the unwanted hypothesis will be 
accepted as a result of the investigation.5 
Our Bayesian considerations of the researcher’s individual rationality thus 
leave us only with a very weak instrument of criticism. Only if the design of the 
                                                          
5  For instance, all the epidemiological studies on vinyl chloride mentioned above did end up 
acknowledging a causal connection between exposure to vinyl chloride and angiosarcoma of 
the liver (where the evidence was so strong that the strategies of re-interpreting the data that 
were applied to the case of brain cancer could not have possibly worked). Even in the 
defectively designed studies on bisphenol A, the probability of registering an effect was 
arguably not zero, as the strain of rat that was used is apparently not totally unresponsive to 
estrogenic substances (cf. vom Saal and Hughes 2005, p. 929). 
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investigation absolutely precludes that acceptance (or rejection) of H could ever 
emerge as its result, can this be diagnosed as indicating an infringement of the set 
of conditions c > k > e, c' > k' > e' and in that sense reflecting an invalidation of the 
epistemic character of the investigation. However, in realistic cases such as the two 
just revisited, it will be plausible to assume that the evaluations at work resulted in 
utilities that lie very close together for c, k and e, while c', k' and e' are spaced 
widely apart (taking H to be the hypothesis that the respective substance does have 
adverse health effects), resulting in a much lower tolerance for the risk of falsely 
accepting H than for the risk of falsely rejecting H. But to call such an uneven 
spacing of utilities “bias” would mean disqualifying a lot of research that we 
usually estimate highly and unhesitatingly consider purely epistemic (think of the 
utility structure that one must presume to underlie most basic research in physics 
with regard to the hypothesis: “There exists a uniform representation of the laws of 
nature”). 
6. Trust and bias: The perspective of social epistemology 
From the vantage point of individualist epistemology, informed by the insight that 
purist strictures of value-free science cannot be generally upheld, it thus still 
appears that the cases described at the outset simply reflect the variability of 
scientific procedure under different admissible value judgments. Remarkably, this 
is not how the biomedical research community seems to regard the matter. Instead, 
the community employs a variety of social mechanisms in order to set up 
conventional standards to prevent just the kinds of phenomena that the cases from 
section 1 represent.  
This has recently been prominently visible in the case of publication bias. To 
prevent (among other things) the practice of making only favorable results publicly 
known and sweeping unfavorable ones under the carpet, several organizations 
have started efforts to register all clinical trials at their inception. The registries are 
intended to be freely accessible and searchable. Most notably, the International 
Committee of Medical Journal Editors has made registration a condition of 
consideration for publication in its member journals.6 In addition, several 
organizations of the biomedical community have issued recommendations to 
                                                          
6  ICMJE 2007, p. 22. Registration of all clinical trials is also endorsed by, e.g., the World 
Association of Medical Editors and the Association of American Medical Colleges (AAMC) 
(WAME 2007, Korn and Ehringhaus 2006, p. 2). 
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academic researchers to make sure that research outcomes cannot be suppressed 
under the terms of the research contracts they sign.7  
Aspects of experimental design are also frequently targeted by conventional 
standards proposed and discussed within the biomedical research community. For 
example, a peer review panel on low dose effects of endocrine disrupting 
chemicals (which include bisphenol A), organized in 2001 by the US National 
Toxicology Program at the request of the Environmental Protection Agency, made 
several recommendations for future study design, including the following: 
“Because of clear species and strain differences in sensitivity, animal model 
selection should be based on responsiveness to endocrine active agents of concern 
(i.e. responsive to positive controls), not on convenience and familiarity.” (NTP 
2001, p. vii.)8 This methodological rule would obviously exclude the CD-SD rat 
from use for bisphenol A studies. In the case of our second example of biased 
experimental design, substandard comparison of drugs (like in the case of 
fluconazole), a respective conventional standard of the biomedical community can 
be found in §29 of the Declaration of Helsinki: “The benefits, risks, burdens and 
effectiveness of a new method should be tested against those of the best current 
prophylactic, diagnostic, and therapeutic methods.” (WMA 2004, p. 4.)9 
Questions regarding the interpretation of outcomes may seem least amenable 
to clearly expressible standards. A development of interest with respect to the 
repeated unusual interpretations of epidemiological data concerning the 
association of vinyl chloride with brain cancer is that more and more editors of 
medical journals now demand the declaration and publication of authors’ financial 
interests (ICMJE 2007, pp. 8-9, WAME n.d.). In contrast to this, the fact that 
Richard Doll’s vinyl chloride review was commissioned and paid for by the 
chemical industry was only revealed in a lawsuit twelve years later (Sass et al. 
2005, p. 810) and additional heavy financial ties with the chemical industry came 
out only after Doll’s death (Boseley 2006). But even on a more specifically 
                                                          
7  These include the American College of Physicians–American Society of Internal Medicine 
(Coyle 2002, p. 400) and the AAMC (Korn and Ehringhaus 2006, p. 2). The ICMJE (2007, p. 9) 
suggests that editors “may choose not to consider an article if a sponsor has asserted control 
over the authors’ right to publish.” 
8  This very specific recommendation echoes the common and more general methodological 
advice to take special care in choosing proper controls in animal research, and to take into 
account that “[m]ore than one control is frequently required” (Johnson and Besselsen 2002, p. 
206). Cf. also Festing and Altman 2002, p. 248. 
9  While this principle (sometimes called “equipoise” or the “uncertainty principle”) was 
originally introduced as an ethical principle in order to protect trial participants, its 
methodological relevance is now widely recognized in the biomedical research community (cf. 
Dietz 2007, Djulbegovic et al. 2000). 
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methodological level, seminal attempts to propose standards for preventing bias 
can be found. In a methodological paper discussing review articles and meta-
analyses, an international group of epidemiologists suggests that each 
epidemiological overview needs an explicit description in the study protocol of 
how studies are selected to be included in the overview and that the analysis 
should then make use of “all studies that are relevant according to the explicit 
inclusion criteria” (Blettner et al. 1999, p. 3). The consistent adherence to this 
admonition would prevent the kind of ad hoc re-interpretation of the database for 
a single result which allowed Doll to downplay mortality from brain cancer in his 
vinyl chloride review.  
It appears that for each of the cases of preference bias we have considered, 
there exist conventional standards that have been proposed and discussed in the 
biomedical research community which would, if adhered to, act as 
countermeasures to these kinds of phenomena. The conventional standards are 
methodological, but in a broader sense (since they also include recommendations 
concerning the dissemination and publication of results), and they come in varying 
degrees of bindingness, explicitness and generality. They do not generally have the 
status of strict, codified and generally accepted methodological rules; it is plausible 
that some of them are hardly ever explicitly formulated except when an 
infringement needs to be criticized. 
Nonetheless, the conventional standards are discernible, and the fact that 
members of the research community appeal to them when criticizing the work of 
others testifies to their relevance. In the present context, the existence of 
conventional standards poses two important questions. Firstly, the presence of 
conventional standards within the respective research community seems to 
reinforce the intuitive feeling that the examples we have considered which infringe 
upon such standards constitute instances of epistemic failure. Why? Secondly, the 
standards all impose implicit restrictions on the ways in which the free exertion of 
evaluative judgment may determine the balance of inductive risk (as considered in 
section 5). If value judgments are part and parcel of the research process at 
virtually each and every step, as has been suggested, then how can such 
restrictions be justified? 
In the remainder of this paper, I would like to propose an analysis of 
conventional standards of a research community that will turn them into a key 
element for understanding the epistemological failure in preference bias and at the 
same time will serve to answer the two questions of the preceding paragraph. This 
analysis will require us to give up the perspective of individual rationality and 
consider the wider picture of social epistemology instead. I suggest that a 
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conventional standard represents an effort of a research community’s members to 
coordinate their practices in order to enable and preserve epistemic trust in their 
research results. 
Trust plays a decisive role for the social epistemology of the sciences for at 
least two (interrelated) reasons: First of all, the division of cognitive labor within 
science requires researchers to estimate reliably the dependability of each other’s 
results. In addition, science has epistemological roles for society at large—specific 
roles that are central to the knowledge situation of each member of society, similar 
in kind (if not in the specifics) to the special roles of journalism. Roughly speaking, 
these roles center on the production of a certain kind of new knowledge with a 
high degree of reliability. One need not spell this out more precisely in order to 
realize that the fulfillment of such roles requires widespread epistemic trust in the 
results of scientific research. As a matter of fact, the importance of trust is often 
emphasized in the discussion of conventional standards. For instance, in a 
background report to one of the more explicitly normative documents we have 
been drawing from above (see notes 6 and 7), the authors, who represent a task 
force of the Association of American Medical Colleges, declare as their objective 
“to preserve public trust in clinical research while sustaining medical progress” 
(AAMC 2001. p. 1). They explain that “the public insists that universities […] 
continue to serve society as trusted and impartial arbiters of knowledge” (ibid., p. 
24).  
Epistemic trust in research outcomes can only develop and stabilize if it is 
possible to make realistic estimates of their dependability. The social epistemology 
of science thus requires that all kinds of actors within and without science develop 
differentiated attitudes of confidence towards different kinds of institutionally 
sanctioned scientific “results”. But typically they cannot appraise the underlying 
value-judgments at work. This threatens to thwart any attempt to assess the 
dependability of a result, because as we have seen, value structures have a strong 
bearing on the admissible error probabilities within a test procedure. In this 
situation, research communities adopt conventional standards that impose implicit 
constraints on acceptable error probabilities. Ideally this makes it possible for 
individual epistemic actors to develop a reliable sense for the dependability of 
certain kinds of scientific outcomes (such as the conclusions of epidemiological 
meta-analyses) on the basis of their experience and their knowledge of the 
procedures, but without knowing in each case which of the outcomes would have 
been the one preferred by the investigators. The conventional standards are 
solutions to coordination problems (as, according to David Lewis [1969, ch. 1], all 
conventions are). It does not matter so much which specific balance of inductive 
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risks is implied by the standard, but rather that there is a standard which is 
dependably observed by everyone in the community. With the help of such 
entrenched standards, users can learn to appraise the reliability of different kinds 
of research results. Obviously, this still requires a lot of skill and knowledge, as 
standards can differ for different kinds of procedures and different research 
communities. But the crucial advantage remains that users do not have to guess at 
the researchers’ value-judgments. The standards adopted are arbitrary in the sense 
that there could have been a different solution to the same coordination problem, 
but once a specific solution is socially adopted, it is in a certain sense binding. For 
example, how grave an epistemic mistake it is to ignore positive controls is 
determined by an epistemic environment in which consideration of all relevant 
controls is taken for granted (and therefore relied upon)—just as how grave an 
endangerment of traffic it is to drive on the left is relative to a social environment 
that strictly obeys the rule to drive on the right. I am not arguing that all 
conventional methodological standards that are actually in effect are optimal 
solutions to the problem of coordinating the collective effort to enable and preserve 
epistemic trust—research communities obviously sometimes amend and change 
standards. But as long as a conventional methodological standard is well-
entrenched and not openly challenged, that fact itself acquires a specific social-
epistemological significance. It is the disregard of important and entrenched 
collective trust-enabling measures that we perceive as epistemic failure in cases 
where the conventions are disobeyed. 
It might be tempting to speculate that the conventional standards should 
typically strike a symmetric balance of inductive risks, i.e. that they should tend to 
avoid L-bias and thereby employ epistemic purity (in the sense discussed in 
section 4) as a regulative ideal.10 In practice, however, many standardized research 
practices can not be regarded in that way. For example, significance testing, the 
most common statistical approach, is designed to provide “severe tests” only in 
one sense, namely that they impose a demanding evidential hurdle for accepting 
the claim that an effect actually exists. On the other hand, such tests normally are 
unable to provide a well-defined distinction between suspending judgment and 
rejecting the claim that there is an effect. The method is clearly designed to avoid 
the mistake of falsely admitting the existence of an effect where really there is none 
(type I error) and implicitly presupposes that this is the more serious one of the 
two errors (cf. Levi 1962, pp. 58-63). As they stand, classical significance tests are 
                                                          
10  This might often be the proclaimed aim of documents proposing conventional standards, 
which frequently contain the assertion that the problem at hand was bias and how to avoid it. 
Cf. ICMJE 2007, WAME n.d., Korn and Ehringhaus 2006, p. 1, AAMC 2001, p. 1, Coyle 2002, 
p. 400. 
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therefore unsuitable for the avoidance of L-bias. This is notable, because 
significance testing is itself an important standardized procedure and many 
conventional standards of hypothesis testing are embedded in its methodology, 
e.g. the widespread conventional choice of .05 as the highest reasonable 
significance level. Clearly, such conventional standards as those related to 
significance testing also place constraints on the implicit utility structure of the test 
situation and on the admissible error probabilities. Its implicit preference structure 
is not symmetric, but nevertheless its specific asymmetry is one that is well-
entrenched in scientific practice and is thereby trust-enabling.11 
As we have seen, each of the cases considered in section 1 breaches one or the 
other convention of the kind that is adopted by research communities in order to 
be able to fulfill their social epistemological roles. This insight can finally lead to a 
more refined definition of preference bias: Preference bias is the infringement of an 
explicit or implicit conventional standard of the respective research community in 
order to increase the likelihood of arriving at a preferred result. The intuition that 
preference bias constitutes epistemic failure (rather than just being a matter of 
differing value judgments) can thus finally be captured within the framework of 
social epistemology. Note that the fact that the conventional standards are 
sometimes vague and often only implicit accounts for a wide grey zone in the 
identification of preference bias. 
Preference bias, thus defined, shows that cases exist in which the shifting of 
the balance of inductive risks in accord with individual preferences is rightfully 
regarded as an unequivocal epistemic mistake, regardless of the values we happen 
to hold. I do not claim that this concept of preference bias covers all possible 
epistemological problems caused by undue influence of preferences. For instance, 
it might be claimed that sometimes the conventional standards of a research 
community are themselves distorted by interests and preferences in an 
epistemologically problematic way.12 Obviously, this kind of claim will have to 
await an explication that differs from my analysis of preference bias. 
Note that I am not at all arguing that science is free of individual value-
judgment after all, or even that the ways in which value-judgments can inform the 
balance of inductive risks are always conventionally restricted. I do not believe that 
crucial decision situations in science are generally amenable to rules and standards 
                                                          
11  I am indebted to Birgitte Wandall for helpful discussion on an earlier, misguided predecessor 
of this paragraph. 
12 This possibility might be illustrated by Shrader-Frechette’s (2004) claim that many 
shortcomings of the suggestions of the International Commission of Radiological Protection 
can be traced back to problematic methodological assumptions employed in the research 
underlying them. 
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in a similar way as more or less standardized procedures. I do not think there can 
be value-free decisions, for example, to adopt a whole theory, or to accept or reject 
a novel method. The acceptable error probabilities in these areas of scientific 
practice are at best constrained by the conditions of relaxed purity discussed in 
section 5. Nevertheless, there are many procedures and aspects of research that are 
subject to stronger constraints, imposed by entrenched conventional standards of 
the community. 
One point that remains to be addressed is the possible concern that this 
analysis of preference bias is somehow not social enough for an analysis from the 
vantage point of social epistemology. After all, it builds on conventional standards 
which, while socially constituted, could in principle be observed by individuals. In 
contrast, other social epistemologists have maintained that science asserts or 
should assert its objectivity through norms and procedures that themselves 
operate on a social level, by guaranteeing such social principles as equality of 
intellectual authority and recognized avenues of criticism within a pluralistic 
scientific community (Longino 1990, ch. 4).13 But surely, the research community 
can and will take diverse measures in order to preserve the trust that is the basis of 
their existence. These will plausibly include both methodological standards and 
norms that affect social organization and interaction.14 In this paper, my concern 
was to find out what is wrong with a certain kind of phenomenon that bears the 
appearance of epistemic failure—even if taken individually. (One does not seem to 
need to consider the question of how many other non-industry studies on 
bisphenol A there were in order to find fault with the industry-funded ones.) My 
claim is that in these cases, the problem lies with the violation of conventional 
methodological standards and that the latter should be regarded as efforts to 
coordinate admissible error probabilities for certain procedures within a 
community. The analysis is therefore an essentially social one. 
The parallel existence of “methodological” and other, more obviously 
“social” safeguards of trust and objectivity is also good to bear in mind when it 
comes to the consideration of practical consequences. The fact that the original sin 
in cases of preference bias is the infringement of a conventional methodological 
standard of the research community does not imply that the most effective remedy 
against the widespread phenomenon of preference bias may not operate on the 
social level. Such social measures could for example consist in efforts to 
                                                          
13  Similarly, Miriam Solomon (2001, esp. ch. 8) finds no fault with individual biases (except that 
she objects to the term “bias”) and even regards them as productive as long as they are not 
poorly distributed within the community.  
14  On Longino’s own view (2002, pp. 130-131, 145-146), shared public standards of inquiry play 
an essential role in shaping and defining a cognitive community.  
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counterbalance the increasing amount of research funded by interested parties 
with publicly funded research, or otherwise to institutionally organize the carrying 
out of, say, clinical trials in a way that precludes sponsors’ influence on the 
research outcomes (cf. Biddle 2007). 
7. Conclusions 
I have maintained that preference bias consists in the infringement of conventional 
standards entertained by the respective research community. This analysis 
captures the intuition that preference bias constitutes an epistemic shortcoming, as 
the conventional standards themselves are adopted by the community in an effort 
to make possible and preserve epistemic trust and to ensure the community’s 
capability of fulfilling its epistemological roles. It also explains why the diagnosis 
of preference bias is often not a clear-cut case, as the conventional standards at 
issue come in different degrees of explicitness and universality. 
As a second conclusion, we should note that an analysis of preference bias as 
an epistemic shortcoming was only possible by viewing it from the perspective of 
social epistemology. The differing frameworks of individual rationality we 
considered were instructive with regard to the connection between inductive risk 
and certain concepts of bias, but they did not offer us any definitive and realistic 
constraints in order to draw a line between the inevitable value-ladenness of 
science and unacceptable preference bias. According to the picture that has 
emerged from our investigation, that line is only socially constituted through the 
development of conventional trust-preserving standards. 
The third and last conclusion which I would like to stress is that these 
standards reveal continuing restrictions of the epistemologically legitimate control 
of researchers’ individual value-judgments over the balance of inductive risks. The 
dominion of the standards is limited to certain procedures and aspects of the 
research process that are particularly amenable to regulation by explicit and 
implicit rules. But as the examples discussed in this paper show, these limited 
aspects can sometimes be of vital importance. Though the criticism of the 
traditional conception of value-free science has brought important insight, a 
picture of science as an open playing-field for individual value-judgments would 
therefore be exaggerated. 
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